These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 729527)

  • 1. [Effect of triquinol on the central nervous system].
    Nikolov M; Stefanova D
    Eksp Med Morfol; 1978; 17(4):194-201. PubMed ID: 729527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the antihistamine preparation, phencarol, on the central nervous system].
    Kaminka ME; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(2):148-53. PubMed ID: 6108233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A neuropharmacological study of isoteolin (IST)].
    Markov M; Zheliazkov D
    Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropharmacological screening of a group of N1-substituted N4-guanylpiperazines].
    Ianeva I
    Eksp Med Morfol; 1985; 24(4):35-9. PubMed ID: 3833522
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropharmacological activity of 2 newly synthesized compounds from the piperazine group. I. The effect on experimental models of excitation and inhibition of the central nervous system].
    Ianeva-Balabanska I; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1986; 25(3):15-9. PubMed ID: 3757874
    [No Abstract]   [Full Text] [Related]  

  • 11. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cocaine molecule fragments on the central nervous system].
    Zakusov VV; Kostochka LM; Skoldinov AP
    Biull Eksp Biol Med; 1978 Oct; 86(10):435-8. PubMed ID: 708871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new centrally acting muscle relaxant 7-chloro-N,N,3-trimethylbenzo[b]furan-2-carboxamide on motor and central nervous systems in rats.
    Ono H; Saito K; Kondo M; Morishita S; Kato K; Hasebe Y; Nakayama M; Kato F; Nakamura T; Satoh M
    Arzneimittelforschung; 1990 Jul; 40(7):730-5. PubMed ID: 2222548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of narcotic analgesics on the central nervous system as an index of their drug addiction potential].
    Bantutova I; Iakimova K
    Farmakol Toksikol; 1991; 54(1):21-3. PubMed ID: 1677621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute toxicity and the central effect of 1-(m-chlorophenyl)-3-N,N-dimethylcarbamoyl-5-methoxypyrazole (PZ-177)].
    Tsurumi K; Go K; Fujimura H
    Nihon Yakurigaku Zasshi; 1976; 72(1):31-9. PubMed ID: 986348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.